Where does Establishment Labs S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Establishment Labs S.A. ranks #10,921 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Establishment Labs S.A. hold?

Establishment Labs S.A. holds 28 US utility patents granted between 2018 and 2025, spanning 14 technology areas.

What is Establishment Labs S.A.'s Innovation Score?

Establishment Labs S.A. has an Innovation Score of 45.1 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Establishment Labs S.A.'s patent grant rate increasing or decreasing?

Establishment Labs S.A.'s recent grant velocity is +1050% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Establishment Labs S.A.'s patents?

Establishment Labs S.A.'s patents average 18.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Establishment Labs S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Establishment Labs S.A.

Q: What technology areas does Establishment Labs S.A. focus on?

Establishment Labs S.A.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 27 patents, ranking #238 of 3,082 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 28 granted patents across 14 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Establishment ranks #10,921 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 14 technology areas.

#10,921
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.1/100): 18.2
avg claims per patent: +1050%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10921 · Foreign Corporation #10,921 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #10,921/49,997
PHOTO-FINISH EchoNous
CPC-FOCUS A61F · 14 areas
INNOV-PAR 45.1/100
CLAIMS-RICH 18.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +1050% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: EchoNous, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Establishment’s 45.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (26%) Velocity 9.3 pts (21%) Breadth 13.2 pts (29%) Claim depth 10.9 pts (24%)

Qualcomm Incorporated · highest

85
Accuride International · near

45
Establishment Labs · this assignee

45
Flir Systems AB · near

45
Thermo Electron… · near

45
Vulcan · near

45
3D Lighting… · lowest

7

What this shows Establishment's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Establishment?

Each dot is one of Establishment’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Establishment’s own 18.2 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Establishment vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Establishment's grants concentrate

Establishment Labs S.A. is a focused PatentsView assignee: 14 CPC subclasses with 96.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2018. By volume, Establishment sits between Endomagnetics Ltd and Fram Group IP, LLC.

Establishment's three-year grant acceleration

Establishment Labs S.A. shows 14 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Endomagnetics

28
Enernoc

28
Echonous

28
Encore Packaging

28
Euro-celtique

28
Evonik

28
FM Marketing

28
Fram Group IP

28
Establishment Labs ◀

28

What this shows Establishment holds 28 patents at rank #10,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Establishment

By rank, the assignees closest to #10,920 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Establishment's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Establishment, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Establishment ranks #238 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Vulcan Inc. 45 Accuride International GmbH 45 Thermo Electron Scientific Instruments LLC 45 Flir Systems AB 45

Establishment's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Establishment Labs S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	3.6%
2019	1	3.6%
2020	3	10.7%
2021	6	21.4%
2022	2	7.1%
2023	8	28.6%
2024	4	14.3%
2025partial year	3	10.7%

Which technologies does Establishment Labs S.A. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 27

A61B - DIAGNOSIS; SURGERY; Identification 17

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 8

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 6

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 6

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 4

G03F - Photomechanical Production OF Textured OR Patterned Surfaces, e.g. FOR Printing, FOR Processing OF Semiconductor DEVICES; Materials THEREFOR; Originals THEREFOR; Apparatus Specially Adapted THEREFOR; 4

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 4

H01J - Electric Discharge Tubes OR Discharge Lamps 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

G06T - Image Data Processing OR Generation, IN General 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

H04N - Pictorial Communication, e.g. Television 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Establishment Labs S.A.'s patent record in context - here's where to go next.

Establishment Labs S.A.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 96.4% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #10,921 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Establishment Labs S.A. against Endomagnetics Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.